BioNTech SE (BNTX) Interest Expenses (2018 - 2025)

BioNTech SE has disclosed Interest Expenses across 8 years of filings, most recently posting -$4.9 million for Q4 2025.

• Interest Expenses for Q4 2025 came in at -$4.9 million, up 63.69% year-over-year; the trailing twelve-month figure through Dec 2025 was -$77.9 million (down 121.29% YoY), and the FY2025 annual result was -$78.9 million, down 169.34% from the prior year.
• Interest Expenses came in at -$4.9 million for Q4 2025 at BioNTech SE, up from -$29.5 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $211.5 million in Q2 2021 to a low of -$162.3 million in Q4 2022.
• The 5-year median for Interest Expenses is -$7.7 million (2024), against an average of -$12.2 million.
• Peak annual rise in Interest Expenses reached 5917.9% in 2021, while the deepest fall reached 14815505.28% in 2021.
• BioNTech SE's Interest Expenses stood at -$2.4 million in 2021, then tumbled by 6656.8% to -$162.3 million in 2022, then jumped by 83.3% to -$27.1 million in 2023, then surged by 50.34% to -$13.5 million in 2024, then soared by 63.69% to -$4.9 million in 2025.
• The last three Interest Expenses figures came in at -$4.9 million (Q4 2025), -$29.5 million (Q3 2025), and -$7.9 million (Q2 2025), per Business Quant data.